Chemistry:Ibrolipim

From HandWiki
Ibrolipim
Ibrolipim structure.svg
Names
Preferred IUPAC name
Diethyl ({4-[(4-bromo-2-cyanophenyl)carbamoyl]phenyl}methyl)phosphonate
Identifiers
3D model (JSmol)
ChemSpider
KEGG
UNII
Properties
C19H20BrN2O4P
Molar mass 451.25
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references
Tracking categories (test):

Ibrolipim (NO-1886) is a cholesterol lowering drug from the statin family, which acts as a lipoprotein lipase activator. The discovery of the "statin" mevalonic acid synthesis inhibitors focused new attention on control of blood lipid levels as a measure to stave off heart disease. A number of compounds have been found that treat elevated lipid levels by other diverse mechanisms. The phosphonic acid derivative ibrolipim is believed to lower those levels by accelerating fatty acid oxidation.[1]

References

  1. "Lipoprotein lipase activator NO-1886". Cardiovascular Drug Reviews 21 (2): 133–42. 2003. doi:10.1111/j.1527-3466.2003.tb00111.x. PMID 12847564.